Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -0.75x is 422% below its 5-year average of 0.23x, near the low end of its 5-year range (-1.58x–2.35x).
82.43% below its 12-month average of -0.41x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2026 (2026-06-30): -0.64x.
INTEREST COVERAGE RATIO
-0.75x
INTEREST COVERAGE RATIO AVG TTM
-0.41x
INTEREST COVERAGE RATIO AVG 3Y
-0.08x
INTEREST COVERAGE RATIO AVG 5Y
0.23x
INTEREST COVERAGE RATIO AVG 10Y
0.31x
INTEREST COVERAGE RATIO AVG 15Y
0.31x
INTEREST COVERAGE RATIO AVG 20Y
0.31x
CURRENT VS TTM AVG
-82.43%
CURRENT VS 3Y AVG
-821.82%
CURRENT VS 5Y AVG
-422.34%
CURRENT VS 10Y AVG
-340.94%
CURRENT VS 15Y AVG
-340.94%
CURRENT VS 20Y AVG
-340.94%
SECTOR MEDIAN · HEALTHCARE
-4.99x
median of 387 covered companies
CURRENT VS SECTOR MEDIAN
+84.97%
vs the sector median at left
Accuray Incorporated
Market Cap
$35.75M
Interest Coverage Ratio
-0.75x
TTM Avg
-0.41x
3Y Avg
-0.08x
5Y Avg
0.23x
Market Cap
$36.29M
Interest Coverage Ratio
-33.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.48M
Interest Coverage Ratio
-87.92x
TTM Avg
13.24x
3Y Avg
16.68x
5Y Avg
16.68x
Market Cap
$34.92M
Interest Coverage Ratio
47.58x
TTM Avg
47.58x
3Y Avg
47.58x
5Y Avg
47.58x
Market Cap
$36.59M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$34.89M
Interest Coverage Ratio
-735.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$37.23M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.93M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$39.28M
Interest Coverage Ratio
-0.13x
TTM Avg
0.53x
3Y Avg
0.64x
5Y Avg
0.43x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Accuray Incorporated (ARAY) | $35.75M | -0.75x | -0.41x | -0.08x | 0.23x |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.29M | -33.29x | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $36.48M | -87.92x | 13.24x | 16.68x | 16.68x |
| Elutia Inc (ELUT)vs › | $34.92M | 47.58x | 47.58x | 47.58x | 47.58x |
| iTonic Holdings Ltd. (ITOC)vs › | $36.59M | N/A | N/A | N/A | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.89M | -735.69x | N/A | N/A | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $37.23M | N/A | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.93M | N/A | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $39.28M | -0.13x | 0.53x | 0.64x | 0.43x |
| HeartBeam, Inc. (BEAT)vs › | $33.42M | N/A | 8.27x | 8.27x | 8.27x |
Interest Coverage
-0.8x
Debt/Equity
4.41
Current Ratio
1.50
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -0.64x |
| 2026-03-31 | -0.30x |
| 2025-12-31 | -0.71x |
| 2025-09-30 | -1.40x |
| 2025-06-30 | 1.00x |
| 2025-03-31 | 0.07x |
| 2024-12-31 | 1.63x |
| 2024-09-30 | -0.73x |
| 2024-06-30 | 2.35x |
| 2024-03-31 | -1.58x |
| 2023-12-31 | -1.36x |
| 2023-09-30 | 0.76x |
| 2023-06-30 | -0.15x |
| 2023-03-31 | 0.85x |
| 2022-12-31 | 1.02x |
| 2022-09-30 | -0.96x |
| 2022-06-30 | 0.99x |
| 2022-03-31 | -0.15x |
| 2021-12-31 | 1.92x |
| 2021-09-30 | 1.18x |
| 2021-06-30 | 1.09x |
| 2021-03-31 | 1.03x |
| 2020-09-30 | 1.25x |
| 2009-06-27 | 7.22x |
| 2008-06-28 | -290.00x |
